Viewing Study NCT06529627



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06529627
Status: COMPLETED
Last Update Posted: None
First Post: 2024-07-26

Brief Title: GDF-8 Levels in ICSI Cycles
Sponsor: None
Organization: None

Study Overview

Official Title: Effect of Growth Differentiation Factor - 8 GDF-8 on Pregnancy Rates in GnRH-agonist ICSI Cycles A Prospective Cohort Study
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study is to investigate the role of GDF-8 in regulating progesterone levels during controlled ovarian stimulation in patients undergoing ICSI-ET and to evaluate its effects on pregnancy rates

The main questions are

Does serum GDF-8 correlate with serum Progesterone levels during ovarian stimulation
Does serum GDF-8 serum level at different time-points during ovarian stimulation correlate with pregnancy rate

participants will undergo ICSI-ET cycle using the long GnRH-agonist protocol and serum levels of GDF-8 and progesterone will be measured at three time-points during the trial on day of hCG trigger administration on day of oocyte pickup and 14 days after embryo transfer
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None